Skip to main content
logo
Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.61
+0.02 (0.05%)
At close: Apr 15, 2026, 4:00 PM EDT
39.05
-0.56 (-1.41%)
After-hours: Apr 15, 2026, 4:40 PM EDT

Centessa Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '20
Revenue
15-6.85--
Gross Profit
15-6.85--
Selling, General & Admin
50.4750.8153.7355.21.14
Research & Development
172.22150.24124.41155.089.3
Other Operating Expenses
---1.98-
Total Operating Expenses
222.69201.06178.14212.2610.44
Operating Income
-207.69-201.06-171.28-212.26-10.44
Interest Income
20.5314.0210.480.24-
Interest Expense
-11.46-10.09-9.91-7.28-0.31
Other Non-Operating Income (Expense)
2.91-35.78-5.432.340.09
Total Non-Operating Income (Expense)
11.98-31.86-4.86-4.69-0.22
Pretax Income
-195.71-232.91-176.14-216.95-10.66
Provision for Income Taxes
1.822.84-25.06-0.75-
Net Income
-197.53-235.76-151.09-216.21-10.66
Net Income to Common
-197.53-235.76-151.09-216.21-10.66
Shares Outstanding (Basic)
13611496934
Shares Outstanding (Diluted)
13611496934
Shares Change (YoY)
18.56%19.02%2.97%2283.79%-
EPS (Basic)
-1.46-2.06-1.57-2.31-0.80
EPS (Diluted)
-1.46-2.06-1.57-2.31-0.80
Shares Outstanding
149.23132.6398.7794.84-
Free Cash Flow
-194.19-142.09-160.51-201.68-10.63
Free Cash Flow Per Share
-1.43-1.24-1.67-2.16-2.71
Gross Margin
100.00%-100.00%--
Operating Margin
-1384.61%--2499.39%--
Profit Margin
-1316.88%--2204.65%--
FCF Margin
-1294.59%--2342.20%--
EBITDA
-206.77-200.11-170.47-212.13-10.44
EBITDA Margin
-1378.47%--2487.57%--
EBIT
-207.69-201.06-171.28-212.26-10.44
EBIT Margin
-1384.61%--2499.39%--
Effective Tax Rate
-0.93%-1.22%14.22%0.34%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q